Summary of Purpose
The purposes of this study are to assess the prevalence of patients with a low risk of stroke or systemic embolism based on a CHA2DS2-VASc score among patients who have an AF-related thromboembolism and to identify the clinical and genetic factors associated with thromboembolism in AF patients with a CHA2DS2-VA score of 0 or 1.Read More →
The following dates are available for this trial. Trial information last updated on 20 October 2017.
|6 Apr 2017||6 May 2017||1 Apr 2018||1 Apr 2019||1 Oct 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Hong Euy Lim, MD, PhD
- Jun Hyuk Kang, MD